Pasithea Therapeutics Corp Stock (KTTA) Forecast
The Pasithea Therapeutics Corp (KTTA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.12, representing a +2,251% increase from the current price of $0.5155. The highest analyst price target is $20.42, and the lowest is $3.82.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KTTA Price Target
Average 15.81 (+2,967% Upside)
Is Pasithea Therapeutics Corp (KTTA) A Buy Now?
Oscillators
Buy: 3 · Sell: 1 · Neutral: 3Summary: Neutral
Moving Averages
Buy: 7 · Sell: 3 · Neutral: 0Summary: Buy
According to our latest analysis, KTTA could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 4 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on KTTA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.02 indicates that KTTA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 56.89 indicates that KTTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 84.23 indicates that KTTA is overbought. This suggests that KTTA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 25.55 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of 111.37 indicates that KTTA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term KTTA price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pasithea Therapeutics Corp financial reports and earnings history, Pasithea Therapeutics Corp (KTTA) stock could reach $17.91 by 2030, $92.46 by 2040 and $209.38 by 2050. See the projected annual prices until 2050 of the Pasithea Therapeutics Corp stock below:
- Pasithea Therapeutics Corp (KTTA) is expected to reach an average price of $36.59 in 2035, with a high prediction of $49.56 and a low estimate of $36.85. This indicates an +6,997% change from the last recorded price of $0.5155.
- Pasithea Therapeutics Corp (KTTA) stock is projected to chart a bullish course in 2040, with an average price target of $69.44, representing an +13,371% change from its current level. The forecast ranges from a conservative $69.44 to a sky-high $92.46.
- Our analysts predict Pasithea Therapeutics Corp (KTTA) to change +22,687% by 2045, soaring from $116.93 to an average price of $117.47, potentially reaching $144.50. While $116.93 is the low estimate, the potential upside is significant.
- Pasithea Therapeutics Corp (KTTA) stock is expected to climb by 2050, reaching an average of $176.50, a +34,139% change from its current level. However, a wide range of estimates exists, with high and low targets of $209.38 and $176.80, respectively, highlighting the market's uncertainty.
Pasithea Therapeutics Corp Stock (KTTA) Year by Year Forecast
Pasithea Therapeutics Corp Stock (KTTA) Price Forecast for 2026
The predicted value for Pasithea Therapeutics Corp (KTTA) in 2026 is set at an average of $3.13. Estimates vary from a peak of $119.27 to a trough of $0.3448, indicating an +508.13% surge from the present price of $0.5155.
Pasithea Therapeutics Corp Stock (KTTA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pasithea Therapeutics Corp (KTTA) is $21.88, with a high forecast of $27.80 and a low forecast of $16.97. This indicates an +4,144% increase from the last price of $0.5155.
Pasithea Therapeutics Corp Stock (KTTA) Price Forecast for 2028
In 2028, Pasithea Therapeutics Corp (KTTA) is projected to reach an average price of $24.87, with a high projection of $28.56 and a low estimate of $20.35. This indicates an +4,725% rise from the last price of $0.5155.
Pasithea Therapeutics Corp Stock (KTTA) Price Forecast for 2029
The 2029 price forecast for Pasithea Therapeutics Corp Stock (KTTA) is $20.66 on average, with a high prediction of $23.52 and a low estimate of $18.36. This represents an +3,908% increase from the previous price of $0.5155.
Pasithea Therapeutics Corp Stock (KTTA) Price Forecast for 2030
Pasithea Therapeutics Corp Stock (KTTA) is expected to reach an average price of $15.78 in 2030, with a high forecast of $17.91 and a low forecast of $13.26. This signifies an +2,961% surge from the last price of $0.5155.
